Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom

Thromb Res. 2020 Sep;193:1-4. doi: 10.1016/j.thromres.2020.05.049. Epub 2020 May 29.

Abstract

  1. Venous thrombosis is common in patients with severe COVID-19 pneumonia.

  2. Many of these thromboses may be immunothromboses due to local inflammation, rather than thromboembolic disease.

  3. Anticoagulated patients with COVID-19 pneumonia have a risk of major bleeding.

Keywords: COVID-19; Critical care; Pulmonary embolism; SARS-CoV-2; Venous thromboembolism.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use
  • Betacoronavirus / isolation & purification
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy
  • Critical Care
  • Dalteparin / therapeutic use
  • Extracorporeal Membrane Oxygenation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy
  • Retrospective Studies
  • SARS-CoV-2
  • Tertiary Healthcare
  • Thromboembolism / diagnostic imaging
  • Thromboembolism / drug therapy
  • Thromboembolism / etiology*
  • Thromboembolism / therapy
  • Ultrasonography, Doppler
  • United Kingdom / epidemiology
  • Young Adult

Substances

  • Anticoagulants
  • Dalteparin